Use of a multimarker blood test in the heterogenous memory clinic setting: an updated and simplified interpretation tool
Plasma marker results of new patients are easily interpretable with our visualization tool. Grey zones are generally small, benefitting the confidence of plasma biomarker use in routine dementia practise.
Authors
- Martijn C. Schut (ORCID: https://orcid.org/0000-0003-4591-9646)
- Calvin Trieu (ORCID: https://orcid.org/0000-0001-6266-2198)
- Afina W. Lemstra (ORCID: https://orcid.org/0000-0002-8933-3260)
- Michelle Barboure
- Inge M.W. Verberk
- Sinthujah Vigneswaran
- Elsmarieke van de Giessen
- David H Wilson
- Lynn Boonkamp
- Yolande A.L. Pijnenburg
- Argonde C. van Harten
- Anouk den Braber
Institutions
- Amsterdam Neuroscience (NL)
- Quanterix (United States) (US)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_106371
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00